| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Clinicians’ Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, “Real-Life”, Case-Control Study
|
Parisi, Alessandro
|
|
|
20 |
4 |
p. 318-325
|
article
|
| 2 |
Colonic Squamous Cell Carcinoma in a Patient With Lynch Syndrome: Case Report and Highlights on the Role of Biomarker-Led Management
|
Kussaibati, R.
|
|
|
20 |
4 |
p. e226-e232
|
article
|
| 3 |
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report
|
Calegari, Maria Alessandra
|
|
|
20 |
4 |
p. 364-367
|
article
|
| 4 |
Cutaneous Lymphangitic Carcinomatosis as the First Sign of Recurrent Malignancy in a Patient With a History of Rectal Adenocarcinoma
|
Lebeck Lee, Cody
|
|
|
20 |
4 |
p. 368-371
|
article
|
| 5 |
Editorial Board
|
|
|
|
20 |
4 |
p. A1
|
article
|
| 6 |
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study
|
Lai, Eleonora
|
|
|
20 |
4 |
p. e253-e262
|
article
|
| 7 |
Mucinous Adenocarcinoma Predicts Poor Response and Prognosis in Patients With Locally Advanced Rectal Cancer: A Pooled Analysis of Individual Participant Data From 3 Prospective Studies
|
Zhang, Jianwei
|
|
|
20 |
4 |
p. e240-e248
|
article
|
| 8 |
Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer
|
Guerrera, Luigi Pio
|
|
|
20 |
4 |
p. 354-358
|
article
|
| 9 |
Outcomes of Patients With Metastatic Anal Cancer According to HIV Infection: A Multicenter Study by the Latin American Gastrointestinal Oncology Group (SLAGO)
|
Mattos, Bruna R.S.
|
|
|
20 |
4 |
p. 299-304
|
article
|
| 10 |
Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer
|
Alshammari, Kanan
|
|
|
20 |
4 |
p. 334-341
|
article
|
| 11 |
Primary Adrenal Insufficiency and Acute Cardiomyopathy in a Patient With Colorectal Cancer Treated With Dual Immune Checkpoint Inhibitors
|
Kojadinovic, Arsenije
|
|
|
20 |
4 |
p. e249-e252
|
article
|
| 12 |
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients
|
Moretto, Roberto
|
|
|
20 |
4 |
p. 314-317
|
article
|
| 13 |
Relationships Between Köhne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer
|
Sartore-Bianchi, Andrea
|
|
|
20 |
4 |
p. 305-313
|
article
|
| 14 |
Response to Pembrolizumab in Advanced Anal Squamous Cell Carcinoma With High TMB and PD-L1 and PD-L2 Amplification
|
Tostes, Francinne T.
|
|
|
20 |
4 |
p. 350-353
|
article
|
| 15 |
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial
|
Vandeputte, Caroline
|
|
|
20 |
4 |
p. 326-333
|
article
|
| 16 |
Standard-Dose Trifluridine/Tipiracil as Safe Treatment Alternative in Metastatic Colorectal Cancer Patients With DPD Deficiency
|
Schouten, Jeroen F.
|
|
|
20 |
4 |
p. 359-363
|
article
|
| 17 |
Suboptimal Completion Rates, Adverse Events, Costs, Resource Utilization, and Cost Impact of Noncompletion in Oral Adjuvant Capecitabine–Based Chemotherapy in Patients With Early-Stage Colon Cancer
|
Wang, Xue
|
|
|
20 |
4 |
p. e215-e225
|
article
|
| 18 |
Survival Benefit of Repeat Local Treatment in Patients Suffering From Early Recurrence of Colorectal Cancer Liver Metastases
|
Hellingman, Tessa
|
|
|
20 |
4 |
p. e263-e272
|
article
|
| 19 |
Table of contents
|
|
|
|
20 |
4 |
p. A3-A6
|
article
|
| 20 |
The Evolving Field of Neoadjuvant Therapy in Locally-advanced Rectal Cancer: Evidence and Prospects
|
Ominelli, Juliana
|
|
|
20 |
4 |
p. 288-298
|
article
|
| 21 |
The Stage Migration Should be Reconsidered in Stage IIIA Rectal Cancer: Based on Propensity Score Analysis
|
Shin, Jung Kyong
|
|
|
20 |
4 |
p. e273-e278
|
article
|
| 22 |
Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases
|
Mathai, Vinod Kalapurackal
|
|
|
20 |
4 |
p. e233-e239
|
article
|
| 23 |
Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer
|
Guren, Marianne Grønlie
|
|
|
20 |
4 |
p. 279-287
|
article
|
| 24 |
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors
|
Stavraka, Chara
|
|
|
20 |
4 |
p. 342-349
|
article
|
Journal description